ReviewWorld journal of diabetes2016

Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome.

Sanjay Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.